New vaccine trial targets Hard-to-Treat colorectal cancer liver metastases
NCT ID NCT07409805
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase study tests a new vaccine called YMN-136 in 9 people with advanced colorectal cancer that has spread to the liver and has not responded to three prior treatments. The main goals are to check the vaccine's safety and find the best dose. Researchers will also watch for signs that the vaccine helps control the cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.